Jansson, A. M., Røsjø, H., Omland, T., Karlsson, T., Hartford, M.
, Flyvbjerg, A. & Caidahl, K. (2008).
Prognostic value of circulating chromogranin A levels in acute coronary syndromes.
European Heart Journal,
30(1), 25-32.
https://doi.org/10.1093/eurheartj/ehn513Jensen, R. B., Vielwerth, S.
, Frystyk, J., Veldhuis, J., Larsen, T., Mølgaard, C., Greisen, G. & Juul, A. (2008).
Fetal growth velocity, size in early life and adolescence, and prediction of bone mass: association to the GH-IGF axis.
Journal of Bone and Mineral Research (JBMR),
23(3), 439-46.
https://doi.org/10.1359/jbmr.071034Jessen, N., Selmer Buhl, E., Pold, R., Schmitz, O. & Lund, S. (2008).
A novel insulin sensitizer (S15511) enhances insulin-stimulated glucose uptake in rat skeletal muscles.
Hormone and Metabolic Research,
40(4), 269-75.
https://doi.org/10.1055/s-2007-1022546
Jorsal, A., Tarnow, L.
, Flyvbjerg, A., Parving, H.-H., Rossing, P. & Rasmussen, L. M. (2008).
Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy.
Diabetologia,
51(11), 2100-7.
https://doi.org/10.1007/s00125-008-1123-8
Jorsal, A., Tarnow, L.
, Frystyk, J., Lajer, M.
, Flyvbjerg, A., Parving, H.-H., Vionnet, N. & Rossing, P. (2008).
Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy.
Kidney International,
74(5), 649-54.
https://doi.org/10.1038/ki.2008.201
Joseph, G., Tarnow, L., Astrup, A. S.
, Hansen, T. K., Parving, H.-H.
, Flyvbjerg, A. & Frystyk, J. (2008).
Plasma alpha-defensin is associated with cardiovascular morbidity and mortality in type 1 diabetic patients.
Journal of Clinical Endocrinology and Metabolism,
93(4), 1470-5.
https://doi.org/10.1210/jc.2007-1910Knudsen, S. T., Andersen, N. H., Poulsen, S. H., Eiskjaer, H., Hansen, K. W., Helleberg, K.
, Poulsen, P. L. & Mogensen, C. E. (2008).
Pulse pressure lowering effect of dual blockade with candesartan and lisinopril vs. high-dose ACE inhibition in hypertensive type 2 diabetic subjects: a CALM II study post-hoc analysis.
American Journal of Hypertension,
21(2), 172-6.
https://doi.org/10.1038/ajh.2007.2